“…The wavelength-dependent light-absorbing characteristics of each biomolecule enable selective imaging by controlling the laser wavelength. Such selective imaging allows PACT to provide high-spatial-resolution and high-contrast information about structures such as vascular anatomy, using only endogenous biomolecules (e.g., hemoglobin, melanin, lipids, and water). − Moreover, by using exogenous contrast agents that take advantage of wavelength-dependent absorption and inherent molecular sensitivity, PACT can provide physiological information and high-contrast molecular imaging. ,− Moreover, PACT can noninvasively obtain SO 2 information without any contrast agents, unlike conventional approaches that rely on an invasive sensor or exogenous contrast agents (e.g., a CT-guided pO 2 sensor, dynamic contrast-enhanced MRI (DCE-MRI), and PET). ,,, In addition, unlike PET and FLI, PACT can provide 3D tomographic image information based on the depth-resolved signal, can enable in vivo molecular-sensitive pharmacokinetics analysis, and can capture the vascular anatomy with a high spatial resolution. ,− Exploiting PACT’s multiparametric imaging capabilities, this modality has been actively employed in preclinical and clinical oncologic research. − …”